HOME >> MEDICINE >> NEWS
Surgical treatment of migraines reduces sick days and increases employee productivity ASPS study

ARLINGTON HEIGHTS, Ill. With more than 28 million Americans suffering from debilitating migraine headaches each year, employers also suffer through missed days from work and reduced productivity. However, Migraine sufferers who had surgical treatment reduced the amount of time missed from work by 73 percent, according to a study published in the January issue of Plastic and Reconstructive Surgery (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS). Additionally, surgical treatment substantially lowered the annual cost of migraine care for patients, the study found.

"The economic impact of migraine headaches on American businesses is staggering due to the loss of employee time and productivity each year," said ASPS member and study author Bahman Guyuron, MD, clinical professor of plastic surgery, Case Western Reserve University, Cleveland. "By identifying the trigger areas for migraines and performing targeted surgical procedures, we significantly reduced or eliminated their migraines and the amount of time missed from work."

Patients in the study were injected with Botox to help determine which muscles in the forehead, or back of the head, triggered their migraines. Once identified, these muscles were then surgically removed.

Prior to surgery, migraine sufferers missed 4.4 days of work per month, according to the study. After surgery, patients only missed 1.2 days per month and the employee out of pocket expense for annual treatment was reduced from approximately $7,612 to $925.

Plastic surgeons successfully reduced the frequency, intensity or duration of migraines for 92 percent of the patients studied. In fact, the surgical treatment eliminated migraine headaches for 35 percent of the patients studied.

"Before surgery, my patients expressed extreme frustration by not being able to gain control of their lives," said Dr. Guyuron. "They wanted to work or spend time with their family. T
'"/>

Contact: Brian Hugins
847-228-9900
American Society of Plastic Surgeons
30-Dec-2004


Page: 1 2

Related medicine news :

1. Surgical procedure to treat GERD in children found to be ineffective
2. Surgical treatment for obesity appears effective for weight loss and related disorders
3. Surgical skill increases survival for oesophageal cancer surgery
4. Surgical technique may reduce pain after tonsillectomy
5. Surgically placed sling reduces signs of aging in the neck
6. Surgical pain increases risk of infection, study shows
7. From Cow Brains To Surgical Scrubs: Selected Students Will Get A Close-Up Look At Neurosurgery At Brainworks
8. From Houses Of Mercy To Temples Of Surgical Precision -- A New Book Explores The History Of Hospitals
9. A Surgical Semiconductor Laser With More Precision And Power
10. Hormonal treatment improves survival in high-risk prostate cancer patients
11. Chronic pain treatments more effective when taken together, new study shows

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: